Cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation: What's new?

被引：0
|
作者：
Robin, Christine [1 ,2 ]
Leclerc, Mathieu [1 ,2 ]
Fourati, Slim [2 ,3 ]
Beckerich, Florence [1 ]
Redjoul, Rabah [1 ]
Maury, Sebastien [1 ,2 ]
Cordonnier, Catherine [1 ,2 ]
机构：
[1] Grp Hosp Albert Chenevier Henri Mondor, AP HP, Serv Hematol Clin & Therapie Cellulaire, Creteil, France
[2] Univ Paris Est Creteil, Creteil, France
[3] Inserm U955, Eq 18, Lab Virol, Creteil, France
来源：
HEMATOLOGIE | 2018年 / 24卷 / 05期
关键词：
D O I：
10.1684/hma.2018.1395
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
CMV infection and disease are a subject of concern after allogeneic hematopoietic stem cell transplantation (HCT) since more than 40 years. Considerable progresses have been made in the understanding of risk factors, diagnostic methods and management. However, it remains a frequent complication after HCT, with a negative impact on overall survival. The development of new antiviral drugs active on CMV and of CMV vaccines has been a matter of important publications over the last years. At the beginning of an era of switch from preemptive to prophylactic strategies, this review aims to address the rationale of these changes, and especially the results of the large clinical trials which, historically, supported the preemptive strategy and which, nowadays, support prophylaxis.
引用
收藏
页码：295 / 315
页数：21
相关论文
共 50 条
  • [31] Human cytomegalovirus infection: A considerable issue following allogeneic hematopoietic stem cell transplantation
    Zhou, Xinyi
    Jin, Nan
    Chen, Baoan
    ONCOLOGY LETTERS, 2021, 21 (04)
  • [32] The immunosuppressive effect of human cytomegalovirus infection in recipients of allogeneic hematopoietic stem cell transplantation
    S Giebel
    R Maccario
    D Lilleri
    M Zecca
    M A Avanzini
    M Marconi
    A Di Cesare Merlone
    G Campanini
    D Montagna
    P Travaglino
    R Gentile
    S Telli
    D Pagliara
    J Holowiecki
    F Locatelli
    Bone Marrow Transplantation, 2005, 36 : 503 - 509
  • [33] Risk factors for cytomegalovirus infection of 79 allogeneic hematopoietic stem cell transplantation patients
    Tan, Y.
    Liu, X.
    Zhao, Y.
    Su, L.
    Liu, Y.
    Gao, S.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S406 - S406
  • [34] The immunosuppressive effect of human cytomegalovirus infection in recipients of allogeneic hematopoietic stem cell transplantation
    Giebel, S
    Maccario, R
    Lilleri, D
    Zecca, M
    Avanzini, MA
    Marconi, M
    Merlone, AD
    Campanini, G
    Montagna, D
    Travaglino, P
    Gentile, R
    Telli, S
    Pagliara, D
    Holowiecki, J
    Locatelli, F
    BONE MARROW TRANSPLANTATION, 2005, 36 (06) : 503 - 509
  • [35] Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation
    Egli, A.
    Bucher, C.
    Dumoulin, A.
    Stern, M.
    Buser, A.
    Bubendorf, L.
    Gregor, M.
    Servida, P.
    Sommer, G.
    Bremerich, J.
    Gratwohl, A.
    Khanna, N.
    Widmer, A. F.
    Battegay, M.
    Tamm, M.
    Hirsch, H. H.
    Halter, J. P.
    INFECTION, 2012, 40 (06) : 677 - 684
  • [36] Human metapneumovirus infection after allogeneic hematopoietic stem cell transplantation
    A. Egli
    C. Bucher
    A. Dumoulin
    M. Stern
    A. Buser
    L. Bubendorf
    M. Gregor
    P. Servida
    G. Sommer
    J. Bremerich
    A. Gratwohl
    N. Khanna
    A. F. Widmer
    M. Battegay
    M. Tamm
    H. H. Hirsch
    J. P. Halter
    Infection, 2012, 40 : 677 - 684
  • [37] Treatment of CMV infection after allogeneic hematopoietic stem cell transplantation
    Maffini, Enrico
    Giaccone, Luisa
    Festuccia, Moreno
    Brunello, Lucia
    Busca, Alessandro
    Bruno, Benedetto
    EXPERT REVIEW OF HEMATOLOGY, 2016, 9 (06) : 585 - 596
  • [38] Improving Safety of Preemptive Therapy with Oral Valganciclovir for Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation
    Barkam, Corinna
    Kamal, Haytham
    Dammann, Elke
    Diedrich, Helmut
    Buchholz, Stefanie
    Eder, Matthias
    Krauter, Juergen
    Ganser, Arnold
    Stadler, Michael
    BONE MARROW RESEARCH, 2012,
  • [39] Cytomegalovirus (CMV) genotype in allogeneic hematopoietic stem cell transplantation
    Dieamant, Debora C.
    Bonon, Sandra H. A.
    Peres, Renata M. B.
    Costa, Claudia R. C.
    Albuquerque, Dulcineia M.
    Miranda, Eliana C. M.
    Aranha, Francisco J. P.
    Oliveira-Duarte, Gislaine
    Fernandes, Virginio C. A.
    De Souza, Carmino A.
    Costa, Sandra C. B.
    Vigorito, Afonso C.
    BMC INFECTIOUS DISEASES, 2013, 13
  • [40] Letermovir for cytomegalovirus prophylaxis in allogeneic hematopoietic stem cell transplantation
    Azharuddin, Md
    Sharma, Manju
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 149 - 149
12345